CANNSUN MEDHEL GROUP ANNOUNCES FIRST HARVEST OF MEDICAL CANNABIS AND PHASE TWO EXPANSION OF CULTIVATION IN SOUTH AFRICA

We are extremely pleased with the production capabilities of our facility in South Africa. Our vision to create high quality medical cannabis is well underway”

— David Parry

DUBLIN, IRELAND , November 10, 2020 /EINPresswire.com/ — Cannsun Medhel Group PLC (“Cannsun” or the “Company”), a bio-pharmaceutical company focused on developing and commercializing new medicines to optimize human potential with operations in South Africa, Greece, Thailand and Lesotho, today announced its first harvest of medicinal cannabis at its facility located in Cape Town, South Africa. Additionally, Cannsun has initiated ground works in preparation for its 1.5-hectare Phase Two outdoor grow commencing later November 2020, which will complement our 2,500 square meter greenhouse facilities and supporting infrastructure.

Cannsun’s 23 hectare medical cannabis cultivation facility, located near Cape Town, South Africa, was successfully licensed earlier in 2020 and has…